# Topical YR001 Ointment in Adult With Mild to Moderate Atopic Dermatitis

> **NCT06309355** · PHASE2 · COMPLETED · sponsor: **Hangzhou Yirui Pharmaceutical Technology Co., Ltd** · enrollment: 35 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** YR001 ointment
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06309355
- **Lead sponsor:** Hangzhou Yirui Pharmaceutical Technology Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-19
- **Primary completion:** 2025-11-20
- **Final completion:** 2025-11-20
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2025-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06309355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06309355, "Topical YR001 Ointment in Adult With Mild to Moderate Atopic Dermatitis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06309355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*